Cim Investment Management Inc. Boosts Stake in Cigna Group $CI

Cim Investment Management Inc. grew its holdings in Cigna Group (NYSE:CI) by 99.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,705 shares of the health services provider’s stock after buying an additional 1,849 shares during the period. Cim Investment Management Inc.’s holdings in Cigna Group were worth $1,124,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Flaharty Asset Management LLC bought a new stake in Cigna Group in the first quarter worth about $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group during the 1st quarter worth approximately $29,000. Solstein Capital LLC purchased a new position in Cigna Group during the 2nd quarter valued at $29,000. Chilton Capital Management LLC bought a new position in Cigna Group in the 2nd quarter valued at $30,000. Finally, Activest Wealth Management grew its position in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Monday, December 8th. Wells Fargo & Company lowered their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 5th. Sanford C. Bernstein dropped their target price on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research note on Wednesday, November 12th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Cantor Fitzgerald dropped their price objective on Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $331.77.

Cigna Group Trading Up 0.9%

CI opened at $274.70 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market cap of $73.38 billion, a price-to-earnings ratio of 12.12, a PEG ratio of 1.00 and a beta of 0.26. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a fifty day moving average price of $280.44 and a 200-day moving average price of $294.02.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period last year, the business earned $7.51 EPS. The company’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.